News

Eurocine Vaccines initiates process development of the vaccine candidate against chlamydia

Today, Eurocine Vaccines AB (“Eurocine Vaccines”) announces the completion of knowledge transfer and preparations for the development of the manufacturing process to secure the active…

Eurocine Vaccines confirms good immunological effect in preclinical study with the chlamydia vaccine candidate

Eurocine Vaccines AB (“Eurocine Vaccines”) confirms good immunological effect in a preclinical animal study with its chlamydia vaccine candidate. The study confirms that an adapted…

Eurocine Vaccines publishes half-year report for July-December 2020

Eurocine Vaccines AB (“Eurocine Vaccines”) hereby publishes an interim report for the first half year of 2020. Below is a summary of the report. The…

Calendar

Aktieportföljen Live

Eurocine Vaccines will present at Aktieportföljen Live, one of the biggest digital investor event in the Nordics. Aktieportföljen Live is a collaboration between the FacebookRead…

Interim Report

Interim Report July 2020-March 2021 to be published.Read More

Biotech Outsourcing Strategies (BOS) Virtual

Eurocine Vaccines has been invited to present at BOS R&D Outsourcing Week together with Biovian Oy, Turku, Finland. In the presentation, Eurocine Vaccines will describeRead…